|Podcasts|December 9, 2022
Achieving Success in the Rare Disease Space
Author(s)Nicholas Saraceno, Senior Editor
Lessons learned around commercializing new products in this niche sector
Advertisement
Andy Udell, North American president at Calliditas Therapeutics, a specialty pharma company, uncovers the complexities surrounding rare disease product commercialization, while also shedding light on outreach strategies that help spread awareness of new medications.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Overton's FDA Bid, EVERSANA's AI Expansion, and a Landmark Cancer Vaccine
2
Will PBMs' TrumpRx Price Pledge Reach Prescribers?
3
Report: Mail-Order Pharmacy Satisfaction Climbs as Retail Trust Slips
4
AI In Pharmacovigilance: The Commercial and Market-Access Imperative
5